VA
Vineet Agarwal
About Vineet Agarwal
Vineet Agarwal has 16 years in corporate governance. Holds Director role. Currently with 3 companies, including Kapsis Biotech Private Limited and Kindcare Drugs Private Limited. Formerly with 2 companies, such as Biogen Biocare Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Kindcare Drugs Private Limited
U51101DL2015PTC279004
|
Director | 13 Apr 2015 | 2015 | Active |
|
Kabia Medicare Private Limited
U51909UR2021PTC012468
|
Director | 01 Jun 2021 | 2021 | Active |
|
Kabia Humanity Foundation
U85500UT2024NPL017258
|
Director | 23 Apr 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Biogen Biocare Private Limited
U24232MP2006PTC018883
|
Director | 10 Mar 2010 | 2006 | Strike Off |
|
Kapsis Biotech Private Limited
U24290UR2022PTC013626
|
Director | 22 Feb 2022 | 2022 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vineet Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vineet Agarwal
Vineet Agarwal has 16 years in corporate governance. Holds Director role. Currently with 3 companies, including Kapsis Biotech Private Limited and Kindcare Drugs Private Limited. Formerly with 2 companies, such as Biogen Biocare Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Vineet Agarwal is associated with 3 companies as Director.
Vineet Agarwal has expertise in Technology, General Business.
Vineet Agarwal has 16 years in corporate governance.